Revogene GBS LB 410200
Revogene GBS LB 410200 is a medical device (FDA Class I) made by Meridian Bioscience Inc., cleared under FDA 510(k) K170557 on 25 May 2017 and listed in FDA GUDID since 15 Jul 2020 (UDI-DI 00840733102363), active as of 8 Nov 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00840733102363 | Date15 Jul 2020 | StatusListed |
| United States | FDA 510(k)SESE | NumberK170557 | Date25 May 2017 | StatusActive |
Official records
- AccessGUDID record 00840733102363
- FDA 510(k) database K170557
From the FDA record
- Device description
- The Revogene GBS LB assay performed on the Revogene Instrument is a qualitative in vitro diagnostic test designed to detect Group B Streptococcus (GBS) DNA from 18-24 hour LIM Broth enrichments of vaginal/rectal specimen swabs obtained from pregnant women. The Revogene GBS LB assay utilizes Automated sample processing and real-time polymerase chain reaction (PCR) to detect a cfb gene sequence specific to the Streptococcus agalactiae genome. The Revogene GBS LB assay is indicated for the identification of antepartum GBS colonization and does not provide susceptibility results. it is not intended to diagnose or monitor treatment of GBS infection. Culture isolates are needed for performing susceptibility testing as recommended for penicillin-allergic women.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K170557 decided 25 May 2017 Active
- FDA GUDID UDI-DI 00840733102363 listed 15 Jul 2020 Listed
Timeline
- Cleared FDA 510(k) K170557
- Listed FDA GUDID 00840733102363
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Revogene GBS LB
- Generic name
- Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- 410200
- Primary DI / UDI-DI
- 00840733102363
- 510(k) Number
- FDA product code
- NJR, OOI
- GMDN term
- Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class I
- Regulation number
- 866.3740, 862.2570
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT).